"Cisterna Magna" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of three principal openings in the SUBARACHNOID SPACE. They are also known as cerebellomedullary cistern, and collectively as cisterns.
| Descriptor ID |
D002946
|
| MeSH Number(s) |
A08.186.566.166.686.351
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cisterna Magna".
Below are MeSH descriptors whose meaning is more specific than "Cisterna Magna".
This graph shows the total number of publications written about "Cisterna Magna" by people in this website by year, and whether "Cisterna Magna" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2004 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cisterna Magna" by people in Profiles.
-
Cerebrospinal fluid hydrocephalus shunting: cisterna magna, ventricular frontal, ventricular occipital. Neurosurg Rev. 2022 Aug; 45(4):2615-2638.
-
FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation. Nat Genet. 2009 Sep; 41(9):1037-42.
-
Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. J Neurosurg. 2007 Jan; 106(1 Suppl):36-40.
-
Pseudotumor cerebri patients with shunts from the cisterna magna: clinical course and telemetric intracranial pressure data. Neurosurgery. 2004 Nov; 55(5):1094-9.
-
Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery. 2004 Oct; 55(4):943-8; discussion 948-9.
-
Germline and mosaic mutations of FLN1 in men with periventricular heterotopia. Neurology. 2004 Jul 13; 63(1):51-6.
-
Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke. 2002 Nov; 33(11):2681-6.
-
Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery. 2002 Sep; 51(3):761-8; discussion 768-70.
-
Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 1994 May; 34(5):809-13; discussion 813-4.